The change to the use ofa new at) for the(D) (4), ¢the (BD) (4) was implemented on February 27, 2018 however the associated change control (Change Control 92345) remained open as of March 15, 2018.
Inspection Record
Plasma Industries Belgium SCRL — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
There is no written justification for the clarifying imits of(b) (4) as stated in Document 2262 / 14.0 entitle 261 — Appendix |: Production File which is a portion ofthe batch record.
The following deviations (Events) related to (b) (4) were not initiated in a timely manner or are otherwise inadequate: A.
The preventative maintenance program for the hich is used to prepare — (b) (4) for the rocess and the used for CIP was not adequately conducted in year 2016 and 2017.
As per Document(b) (4) 16 entitled “Particle Contamination” a deviation (Event) is not required to be initiated for the detection ofparticles until particle identification is(b) (4) which is allowed to
Discoloration resembling®) @was observed on (b) (4) located in the (®) (4)of the Operations Building Room () ()during a walkthrough ofthe area on 3-12-18.
The current procedure for CIP of the fails to require the initiation of a deviation when an atypical event is detected during the ) ifically, CAPA 81235 was initiated as part ofEvent Record 79659 to update SO clean.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.